CAPR Reminds me of GME The MACD tells an interesting story, rising despite prices fall, if MACD breaks out into the positive region then price may do a full reversal, which would be massive for CAPR
Just made me think of GME
−0.87USD
−22.29 MUSD
25.18 MUSD
28.79 M
About Capricor Therapeutics, Inc.
Sector
CEO
Linda Marbán
Headquarters
San Diego
Website
Employees (FY)
102
Founded
1996
ISIN
US14070B3096
FIGI
BBG000DZMK99
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
CAPR Chart indicatorAll indicators are pushing towards bullish divergence and momentum going into October.
Ain't a big flag but it's honest workThis looks like a small flag to me, fits the volume pattern
I like it
$CAPR Target 7.55 for 42.99%$CAPR Target 7.55 for 42.99%
Or double position at 3.01
RSI Support Bounce — Let’s go all the way…
I have not added since last chart and target is the same.
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my av
$CAPR Target 7.55 for 42.99% $CAPR Target 7.55 for 42.99%
Or double position at 3.01
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible
$CAPR Target 7.61 for 42.51% $CAPR Target 7.61 for 42.51%
Or next add level is at 3.07
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possi
ADDED to $CAPR New Target 7.61 for 42.51% $CAPR Target 7.61 for 42.51%
Or next add level is at 3.07
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possible
ADDED to $CAPR NEW Target 7.74 for 41.50% $CAPR Target 7.74 for 41.50%
Or next add level is at 3.20
—
On the far right of the chart is my Average (Grey) Current Target (Green), and Next Level to add (Red) Percentage to target is from my average.
I start every position with 1% of my account and build from there as needed and as possib
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CAPR is 5.05 USD — it has decreased by 9.01% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Capricor Therapeutics, Inc. stocks are traded under the ticker CAPR.
Capricor Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CAPR stock is 20.60% volatile and has beta coefficient of 0.49. Check out the list of the most volatile stocks — is Capricor Therapeutics, Inc. there?
One year price forecast for Capricor Therapeutics, Inc. has a max estimate of 40.00 USD and a min estimate of 8.00 USD.
CAPR earnings for the last quarter are −0.25 USD whereas the estimation was −0.30 USD which accounts for 17.58% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about Capricor Therapeutics, Inc. earnings.
Capricor Therapeutics, Inc. revenue for the last quarter amounts to 6.19 M USD despite the estimated figure of 3.15 M USD. In the next quarter revenue is expected to reach 10.60 M USD.
Yes, you can track Capricor Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
CAPR stock has fallen by 19.59% compared to the previous week, the month change is a 25.52% fall, over the last year Capricor Therapeutics, Inc. has showed a 19.95% increase.
CAPR net income for the last quarter is −762.09 K USD, while the quarter before that showed −6.39 M USD of net income which accounts for 88.07% change. Track more Capricor Therapeutics, Inc. financial stats to get the full picture.
Today Capricor Therapeutics, Inc. has the market capitalization of 174.84 M, it has decreased by 4.50% over the last week.
No, CAPR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CAPR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Capricor Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 102.00 employees. See our rating of the largest employees — is Capricor Therapeutics, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Capricor Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Capricor Therapeutics, Inc. stock shows the neutral signal. See more of Capricor Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Capricor Therapeutics, Inc. future price: according to them, CAPR price has a max estimate of 40.00 USD and a min estimate of 8.00 USD. Read a more detailed Capricor Therapeutics, Inc. forecast: see what analysts think of Capricor Therapeutics, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Capricor Therapeutics, Inc. EBITDA is −22.80 M USD, and current EBITDA margin is −91.39%. See more stats in Capricor Therapeutics, Inc. financial statements.